Cradle Bio vs Neuralink

Side-by-side comparison of AI visibility scores, market position, and capabilities

Neuralink leads in AI visibility (74 vs 35)
Cradle Bio logo

Cradle Bio

EmergingLife Sciences & BioTech

AI Protein Engineering

Cradle provides an AI platform for protein engineering that accelerates the design of improved enzymes, antibodies, and other biologics for industrial and therapeutic use.

AI VisibilityBeta
Overall Score
D35
Category Rank
#120 of 198
AI Consensus
91%
Trend
stable
Per Platform
ChatGPT
38
Perplexity
36
Gemini
36

About

Cradle Bio is an AI protein engineering company founded in 2021 in Amsterdam, having raised $73M to build an AI-powered protein design platform. The platform combines generative AI with wet-lab experimentation to accelerate the iterative process of engineering proteins with improved stability, activity, and manufacturability. Cradle's technology enables researchers to design thousands of protein variants computationally and prioritize those most likely to succeed in laboratory validation, compressing protein engineering timelines from years to months. The company serves both industrial biotechnology customers engineering enzymes for biomanufacturing and pharmaceutical companies developing next-generation antibody therapeutics. Cradle partners with contract research organizations and biopharmaceutical companies to integrate AI-assisted protein design into existing discovery workflows. The company has been recognized as a leader in the European deep tech ecosystem and positions protein engineering AI as enabling a new era of designed biologics for medicine and sustainable manufacturing.

Full profile
Neuralink logo

Neuralink

LeaderLife Sciences & BioTech

Brain-Computer Interface

Pioneer of implantable BCIs with 12+ active human patients as of Sep 2025; raised $650M Series E in Apr 2026 led by ARK Invest and Sequoia at a ~$14.9B valuation; mass production underway.

AI VisibilityBeta
Overall Score
B74
Category Rank
#3 of 198
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
72
Perplexity
80
Gemini
73

About

Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with paralysis to control digital devices directly with their thoughts. The company's first commercial product, the N1 implant, is a coin-sized device containing 1,024 electrodes that is surgically placed in the motor cortex. As of September 2025, twelve patients worldwide had received the N1 implant and were actively using it to control computers, smartphones, and robotic arms with neural signals alone.

Full profile

AI Visibility Head-to-Head

35
Overall Score
74
#120
Category Rank
#3
91
AI Consensus
79
stable
Trend
stable
38
ChatGPT
72
36
Perplexity
80
36
Gemini
73
35
Claude
76
34
Grok
72

Key Details

Category
AI Protein Engineering
Brain-Computer Interface
Tier
Emerging
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Cradle Bio
AI Protein Engineering

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.